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Abstract
Background:  Protein identification based on mass spectrometry (MS) has previously been
performed using peptide mass fingerprinting (PMF) or tandem MS (MS/MS) database searching.
However, these methods cannot identify proteins that are not already listed in existing databases.
Moreover, the alternative approach of de novo sequencing requires costly equipment and the
interpretation of complex MS/MS spectra. Thus, there is a need for novel high-throughput protein-
identification methods that are independent of existing predefined protein databases.
Results: Here, we present a hybrid method for genome-fingerprint scanning, known as HybGFS.
This technique combines genome sequence-based peptide MS/MS ion searching with liquid-
chromatography elution-time (LC-ET) prediction, to improve the reliability of identification. The
hybrid method allows the simultaneous identification and mapping of proteins without a priori
information about their coding sequences. The current study used standard LC-MS/MS data to
query an in silico-generated six-reading-frame translation and the enzymatic digest of an entire
genome. Used in conjunction with precursor/product ion-mass searching, the LC-ETs increased
confidence in the peptide-identification process and reduced the number of false-positive matches.
The power of this method was demonstrated using recombinant proteins from the Escherichia coli
K12 strain.
Conclusion: The novel hybrid method described in this study will be useful for the large-scale
experimental confirmation of genome coding sequences, without the need for transcriptome-level
expression analysis or costly MS database searching.
Background
Mass spectrometry (MS) is one of the major proteomics
tools of the post-genomic era. Protein identification has
traditionally been conducted by peptide mass fingerprint-
ing (PMF) [1-3] or tandem MS (MS/MS) database search-
ing and, while the former performs well with highly
purified samples, the latter is the de facto standard for
identifying proteins in complex samples. However, these
approaches are only capable of detecting proteins already
listed in databases. PMF implicitly assumes that all genes
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are annotated and that their complete protein sequences,
including post-translational modifications, are known;
however, in reality, most of these sequences are inade-
quately represented in existing databases. As alternative
approaches, de novo peptide sequencing can be performed
by the Edman degradation method [4], MS/MS [5,6], and
controlled protein hydrolysis [7]. However, although
amino-acid sequences can provide specific information
that might be of use in pinpointing gene locations [8,9],
de novo sequencing generally requires the interpretation of
complex MS/MS spectra. The most common method for
protein identification is based on the interrogation of MS/
MS-based databases. Using this approach, the MS/MS
spectra of protein-derived peptide mixtures are matched
to theoretical spectra from protein-sequence databases.
Search engines, such as Mascot [10] or SEQUEST [11],
generate a score reflecting the probability that a given
experimental spectrum originates from a particular pep-
tide. The presence of a related protein in the sample of
interest is then inferred from these data. However, there
remains a need for novel high-throughput approaches,
because de novo sequencing is not suitable for proteome-
wide protein identification, and MS/MS database search-
ing alone is prone to generate both false-positive and
false-negative results.
Recently, novel protein-identification methods that are
independent of predefined protein databases have been
reported [12,13]. In genome fingerprint scanning (GFS),
the peptide data are mapped directly onto raw genomic
sequences by scanning the PMF data against theoretical
peptide masses generated computationally from entire
genomes [12]. This approach can identify the genomic
loci and amino-acid sequences of proteins. However, the
major drawback of this method is that many false-positive
matches can be generated, because precursor ion masses
alone are used to search the genome-wide peptide-finger-
print data.
To reduce the number of false-positive results, and to
improve the efficiency of protein identification, we devel-
oped a hybrid method we term HybGFS. This approach
uses an extended version of the GFS algorithm that
includes the product ion masses and liquid-chromatogra-
phy elution times as additional parameters for peptide
identification. Experimental tandem mass spectra are
searched against theoretical peptide data generated from a
complete genome sequence, evaluated statistically, and
used for genome scanning. In the current study we vali-
dated our HybGFS method using a set of 47 recombinant
proteins from the E. coli K12 strain. A total of 45 (95.7%)
of the recombinant proteins were accurately identified
and mapped to their correct genomic locations. Based on
their amino-acid composition, the peptide LC-ETs were
predicted with an artificial neural network (ANN) model
and utilized for peptide identification. The HybGFS
approach is independent of existing protein databases, in
which the coding sequences of proteins are assumed to be
established, and simultaneously identifies the genetic
loci. Moreover, this novel program does not require the
manual interpretation of mass spectra; rather, it uses auto-
matically generated Mascot [10] generic files, thereby
allowing high-throughput analysis to be realized. We sug-
gest that this improved method of peptide identification
will find many applications in LC-MS-based proteomics.
Results and discussion
Generation of an in silico peptide database
We chose E. coli K12 to validate HybGFS because extensive
genome annotation data are available for this strain and
its protein-coding sequences have been accurately deter-
mined. To identify proteins without reference to existing
databases, we constructed a comprehensive dataset based
on genome-sequence information for a total of 2,536,810
in silico peptides. We first recorded the amino-acid
sequences, the genomic loci and the calculated mass-to-
charge ratio (m/z) values of peptides in the dataset. We
then included the LC-ETs predicted by the ANN model
(see Methods for details). The prediction-accuracy of the
trained ANN model is shown in Figure 1. The correlation
coefficient for both the predicted and experimental ETs
was 0.9755 with a mean prediction error of 1.52 min
(standard deviation [SD] = 1.63 min).
Correlation between experimentally measured and pre- dicted LC-ETs Figure 1
Correlation between experimentally measured and pre-
dicted LC-ETs. Data for all peptides in the training dataset 
obtained through cross validation are shown. The correla-
tion coefficient was 0.9755 and the mean prediction error 
was 1.52 min (SD = 1.63 min).BMC Bioinformatics 2006, 7: http://www.biomedcentral.com/1471-2105/7/479
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Experimental validation of HybGFS
We tested the accuracy of our method by evaluating its
ability to positively identify 47 known protein samples.
The recombinant proteins were purified and digested and
the resulting peptides analyzed by LS-MS/MS. The result-
ant raw MS/MS spectra were automatically converted into
Mascot generic format (MGF) files using Analyst QS soft-
ware (Applied Biosystems, CA, USA). We used the precur-
sor/product ion m/z values and the LC-ETs of the peptides
in the MGF files to obtain the computational parameters.
The m/z error-tolerance values were ± 1 Da for the precur-
sor ion and ± 3.1 min for the LC-ET; the latter was calcu-
lated as the sum of the mean prediction error and the SD
of the error. Based on these parameters, HybGFS accu-
rately identified 45 (95.7%) of the 47 E. coli proteins
tested and their genomic loci without reference to infor-
mation on protein-coding regions.This result confirms
that our method is highly effective for determining both
protein identity and gene location.
To demonstrate the value of the product ion m/z values
and ETs for peptide searching, we repeated these proce-
dures in the absence of one or both of the additional
search parameters (Table1). When the precursor ion m/z
value alone was used, only 2 of the 47 proteins were cor-
rectly identified and the average ranking of the correct
protein among the top hits was 157.83. When we used the
LC-ET and the precursor ion m/z value together, the
number of correctly identified proteins increased to 14
and the average hit ranking was 35.77. When both the pre-
cursor- and product ion m/z values were used in the
absence of LC-ET information, 38 of the 47 proteins were
correctly identified and the average hit ranking was 4.69.
When all 3 parameters were applied simultaneously, the
results were significantly better: 45 (95.7%) of the pro-
teins were correctly identified and the average hit ranking
was 1.85. It should be noted that under the latter condi-
tion, the average hit ranking was mainly due to 2 outlier
proteins, Eda and PfkA. We further compared our valida-
tion results with Mascot search results using the same the-
oretical ORF database and LC-MS/MS data and identical
search parameters, i.e. 2 missed cleavages, peptide charges
(z) of 1–5, error tolerance of ± 1 for precursor, ± 0.8 for
product ion, fixed modification of carboxymethyl, and
the ESI-QTOF instrument (for detail see Methods). Using
Mascot, we found that 41 proteins were correctly identi-
fied with top rank and 3 were ranked within the top 4 can-
didates. The remaining 3 were not identified; 2 of these
(Eda and PfkA) were also not identified with HybGFS and
considered outliers (Table 1). Mascot search parameters
have been debated and we were unable to compare
directly and discuss the identification ability of Mascot
and HybGFS based only on these results. However, our
HybGFS using all 3 parameters (precursor, product ion m/
z, and LC-ET) yielded results that were comparable with
Mascot algorithms.
To evaluate the identification accuracy at the peptide
level, we calculated the positive predictive value (PPV)
index, i.e. number of true-positive peptide identifications/
total number of peptide identifications, of the peptides
for each method (Figure 2). We found that the inclusion
of all 3 parameters (precursor m/z, product m/z, and ET)
yielded the highest PPV index. We also calculated the spe-
cificity and sensitivity of the peptide identifications for
each matching criterion (Table 2). Due to the large pro-
portion of negative entries in the dataset (peptides) and
the difficulties we subsequently encountered in our com-
parison of specificity, the relative values of the false-posi-
tive rate (100-specificity) are also shown. Although
sensitivity was high for identifications without product
ion m/z (precursor ion m/z; precursor ion m/z and ET),
the false-positive rate was also high for these 2 matching
criteria. On the other hand, although sensitivity was low
for identifications using all 3 indices and for identifica-
tions using precursor and product ion m/z, the false-posi-
tive rate was drastically (>300 – 700×) improved
compared with the results obtained without product ion
m/z matching. We ascribe the better result in the correctly
identified protein ranking (Table 1) to these low false-
positive rates.These results indicate the significant effect of
product ion matching on identification. The effect of LC-
ET-based screening is also significant as it reduced the
false-positive rates from 100.0 to 24.522 (precursor ion
m/z and ET), and from 0.134 to 0.073 (precursor, product
ion m/z and ET).
Several protein-identification approaches that do not rely
on existing databases have been developed previously. For
example when Giddingset al.[12] who used the GFS tech-
nique searched experimental peptide masses obtained
from Saccharomyces cerevisiae and E. coli against theoretical
peptide masses, they were able to identify 17 of the 22
samples tested (77.3%). Taking an alternative approach,
Arthur and Wilkins [13] theoretically generated virtual
proteins from a genome cleaved into equal-sized frag-
ments, performed translation into all 6 open reading
frames (ORFs), and compared the results with experimen-
tal data from Mycobacterium tuberculosis. However, they
found that this method was prone to false-positive pep-
tide matches and consequently, ambiguous protein- and
gene-identification results. We opted for a method in
which we applied product ion m/z values and LC-ETs to
realize efficient peptide identification and conclusive pro-
tein inference, and we obtained fewer false-positives.
Unlike some of the older methods, HybGFS is highly prac-
tical as it does not require the manual interpretation of
mass spectra, thus throughput is improved. We suggest
that in conjunction with two dimensional (2D)-PAGEBMC Bioinformatics 2006, 7: http://www.biomedcentral.com/1471-2105/7/479
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and current automated protein spot-handling technolo-
gies, the hybrid technique introduced here will be useful
for both protein- and gene identification. We also think
that our method will prove useful for the annotation of
genomes using experimental data and that it will assist in
the discovery of novel gene products – goals that standard
bioinformatics gene-searching algorithms often fail to
achieve.
Table 1: Target protein ranking among the search hit results using precursor ion m/z values, product ion m/z values, and/or LC-ETs.
Gene Product Rank
Precursor Precursor and ET Precursor and 
Product
All Mascot
Average 157.83 35.77 4.69 1.85 -
PolA 11111
AdhE 11111
PykF 21111
AceE 71111
FumA 91111
AcnA 91111
Pgk 1 0 1111
Eno 1 2 1111
GapA 1 6 1111
Ppc 2 1 1111
SucC 2 5 1111
Pgi 3 0 1111
PtsI 52111
RpiA 1 0 2111
SucB 63111
PykA 83111
FumB 1 0 3111
IcdA 1 1 3111
Gnd 2 8 3111
AceA 3 0 1 3111
LpdA 2 8 4111
Fba 2 8 2 6111
Zwf 5 5 7111
FumC 2 1 1 7111
SucD 3 2 4 7111
TalA 1 5 5 8111
SfcA 5 6 9111
SucA 3 4 1 1 111
Fbp 5 1 2 1 1 111
GpmA 3 4 1 2 111
Acs 1 1 1 1 4 111
PflA 1 3 9 1 4 111
LdhA 2 0 7 2 7 111
PckA 3 2 5 3 1 111
TalB 493 32 1 1 N.I.
AckA 6 1 7 5 0 111
Edd 1 3 9 8 0 114
GpmB 1752 767 1 1 3
PoxB 1 9 2211
Mdh 6 2 4211
PflB 41411
PpsA 2 7 8412
SdhA 2 9 4 2 7 1 711
GltA 129 1 16 1 1
AceB 151 13 16 1 1
Eda 312 15 23 7 N.I.
PfkA 4 2 9 1 57 73 2N . I .
For comparison, the results searched using Mascot software are also shown. Each recombinant protein's name we experimentally tested in the 
validation dataset is listed, as is its ranking in the search results.BMC Bioinformatics 2006, 7: http://www.biomedcentral.com/1471-2105/7/479
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In addition to 3 indices we utilized, other LC-MS-derived
information that reflects the physicochemical properties
of peptides may be usable in HybGFS. For example, Parker
[14] employed peak intensity information to improve the
accuracy of peptide identification in MALDI-MS-based
proteomics. Although a method for the prediction of pep-
tide peak intensity for ESI-MS remains to be established,
we could use this information for more accurate peptide
identification. In addition, the high-resolution mass spec-
trometric approach is useful. The utility of accurate mass
tag- and LC-ET prediction in large-scale peptide identifica-
tion has been discussed elsewhere [15]. Our HybGFS
would further reduce false-positive peptide matches if
high-resolution MS were used in conjunction with LC-ET
prediction.
Scalability of HybGFS to other organisms
In higher eukaryotes, e.g. human and rat, the size of indi-
vidual introns is much larger than in other eukaryotes
(human: 3413.4 bp; rat: 1091.7 bp; Schizosaccharomyces
pombe: 92.7 bp, (mean)) [16]. Furthermore, higher
eukaryotes have multiple introns (human: 4.0 ± 4.3; rat:
3.0 ± 3.3/gene) [16], whereas a yeast gene usually has at
most one intron [17]. Due to difficulties in evaluating
peptide localization on the genome, the application of
GFS methodology to higher eukaryotes comprised of mul-
tiple exons remains a considerable challenge [12]. It is
inherently difficult to identify by the current GFS method-
ology peptides translated over exon/exon junctions and
the existence of alternative splicing variants increases the
possibility of such false-negatives. At least 74% of human
multi-exon genes are alternatively spliced [18] and in
mouse protein-coding transcripts, 79% of splice varia-
tions altered the protein product [19]. Therefore, from a
practical perspective, current GFS methods including our
HybGFS are not scalable to higher eukaryotes at present.
However, HybGFS is not limited to bacteria; we consider
it applicable to lower eukaryotes such as yeast and
Aspergillus, because the intron size and frequency in these
organisms are small [16,17].
Conclusion
We present a new method for mapping peptide sequences
onto their genomic positions using LC-MS/MS data and
genome-sequence information. HybGFS does not require
predefined protein databases or annotated ORF informa-
tion. Our validation results indicate that the use of prod-
uct ion m/z values and peptide LC-ETs in addition to
precursor ion m/z values, as employed in the original GFS
method, significantly reduces the number of false-posi-
tives, a major problem in the traditional GFS method that
results in errors in both mapping and protein identifica-
tion. HybGFS will therefore be useful for large-scale exper-
imental confirmation of coding sequences in genomes
without the need for transcriptome-level expression anal-
ysis or costly MS database searches.
Methods
Pre-compilation of in silico peptides
All possible peptide sequences were generated in silico
using the procedures described below. The genome of the
E. coli K12 strain (GenBank:NC_000913) was down-
loaded via the National Center for Biotechnology Infor-
mation (NCBI) ftp server on January 12, 2004. The
sequence was computationally translated and cleaved
PPV of the peptide-screening algorithm using precursor ion  m/z values, product ion m/z values and/or LC-ETs Figure 2
PPV of the peptide-screening algorithm using precursor ion 
m/z values, product ion m/z values and/or LC-ETs. The PPV 
corresponds to the ratio of correctly identified peptides (i.e. 
peptide sequences included in the validation protein data-
sets) to all identified peptides.
Table 2: Specificity and sensitivity of peptide identifications using precursor ion m/z values, product ion m/z values, and/or LC-ETs.
Sensitivity Specificity FP Rate (Relative Value)
Precursor 41.208 96.038 100.000
Precursor + ET 35.317 99.028 24.522
Precursor + Product 8.467 99.995 0.134
All 9.789 99.997 0.073
Relative values of the false-positive (FP) rate are also shown. The highest FP rate (precursor) was normalized to 100 and other FP rates were 
represented as the ratio to the normalized value. We used this representation of the FP rate to facilitate easier comparison.BMC Bioinformatics 2006, 7: http://www.biomedcentral.com/1471-2105/7/479
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according to the rules for the LysC endopeptidase (Figs.
3A and 3B). Translation of the genome was conducted in
all 6 reading frames, irrespective of the annotated ORFs.
The acceptable number of missed cleavage sites was set at
≤2. For each in silico-generated peptide, the m/z values of
the precursor/product ions, the amino-acid sequences,
and the genomic location were stored in our in silico pep-
tide database (Figure 3C). To calculate the m/z values of
the precursor ions, we assumed that the peptide charge (z)
was between 1 and 5. The b-y series ions, which were the
most abundant under our experimental conditions, were
used to list the m/z values of all possible product ions for
each precursor ion. In addition, the LC-ETs were predicted
using the ANN model (Figure 3D).
ANN model
We developed an ANN model, coupled with a genetic
algorithm-based normalization, according to the basic
method described by Petritis et al. [20]. The model con-
sisted of 20 input nodes, 2 hidden nodes, and 1 output
node. The 20 input vectors corresponded to the numbers
of each of the 20 amino-acid residues making up the pep-
tides. Each input vector was normalized to the maximum
value among all peptides in the training sets; these com-
prised 614 well-known peptides identified by MS/MS
under the same LC-gradient conditions. To reduce the
output error, the 20 input vectors for these peptides were
repeatedly entered into the ANN model using a back-
propagation algorithm. The ANN model was trained
using 500 (81.4%) of the 614 peptides and its predictive
power was evaluated by cross-validation with the remain-
ing data. The correlation coefficient of each validation was
Schematic flowchart depicting the HybGFS method Figure 3
Schematic flowchart depicting the HybGFS method. (A and B) Generation of in silico peptide sequences from a genome 
sequence. (C) Calculation of precursor and product ion m/z values for in silico peptides. (D) LC-ET prediction for in silico-gen-
erated peptides using ANNs. (E) Pre-compilation of in silico peptide information into a database. (F) Querying experimental 
peptide data obtained by MS/MS to the database.
Genome sequence
1
2
3
4
5
6
Location m/z Sequence LC Elution
time
Peptides
In silico transcription and
translation in six frames
In silico enzymatic digest
LC-MS/MS data
In silico peptide database
LC Elution time
prediction by ANN
Calculation of
possible m/z
for
precursor and
product ions
query
Genome sequence
A B
C
D
E
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calculated using least-square approximation and the ANN
weightings with the best correlation coefficients were
adopted to predict the LC-ETs of all the in silico peptides.
After these procedures the genomic loci, precursor/prod-
uct ion m/z values, and predicted LC-ETs for all of the
peptides were calculated and entered into our in silico pep-
tide database (Fig. 3E). All experimental LC-MS/MS data
were queried against this database (Fig. 3F).
Experimental sample preparation and MS
To prepare a validation set for query against HybGFS, His-
tagged proteins were produced using the 'A Complete Set
of E. coli K-12 ORF Archive' (ASKA) library [21]. Clones
were grown in LB medium at 37°C. After 3-h incubation,
1 mM isopropylthiogalactoside (IPTG) was added to
induce the expression of the recombinant proteins. Cells
were harvested by centrifugation at 5,000 rpm for 10 min,
suspended in buffer containing 50 mM sodium phos-
phate and 300 mM NaCl (pH7.0), sonicated on ice, and
stored at -80°C. Protein extracts were centrifuged at 8,000
rpm for 20 min at 4°C and the supernatant was applied to
a Talon metal-affinity chromatography column (Clon-
tech, CA, USA) to purify the His-tagged proteins. These
were eluted in lysis buffer containing 200 mM imidazole.
Protein samples (12.5 μg) were reduced with 1 μl reduc-
tion buffer (1 μg/μl dithiothreitol in water) and alkylated
with 1 μl alkylation buffer (5 μg/μL iodoacetamide in
water). After dilution with Milli-Q water, the proteins
were enzymatically digested overnight at room tempera-
ture with 10 AU/mL LysC endopeptidase. The resulting
peptides were then separated on an Agilent 1100 series LC
system with a Zorbax SB-C 18 3.5-μm reverse-phase col-
umn (2.1 × 50 mm; Agilent Technologies, Palo Alto, CA)
packed with 1.8-μm particles. The mobile phases for the
gradient elution were water (A) and acetonitrile (B), both
with 0.2% formic acid, and the peptides were eluted from
the column using 1–45% gradients of solvent (B). The col-
umn eluent was transferred to an electrospray-ionization
quadrupole/quadrupole time-of-flight (QqTOF) tandem
mass spectrometer (QSTAR; Applied Biosystems, CA,
USA) operated in the positive-ion mode. MGF files con-
taining peak lists and m/z and LC-ET information for each
ion were automatically generated by Mascot.dll script in
Analyst QS software (Applied Biosystems).
Identification of proteins and gene loci
Experimental peptide-fingerprint data for each protein
sample were queried against the in silico peptide database
as follows. In silico peptides were initially searched using
the m/z values of the precursor ions and the associated
ETs. Error tolerances were set at ± 1 Da for the precursor
ions and at ± 3.1 min for the LC-ETs. In silico peptides
within these ranges were selected. Positively-matched
peptides were further screened by MS/MS matching based
on b-y series ions. For each candidate precursor ion, a list
of N product ions with random m/z values was generated,
with N corresponding to the number of experimentally
observed product ions. The number of random product
ions was limited to between 200 and 1,000, which corre-
sponded with the selected MS scan range. The theoretical
product ions (b-y series) for each in silico peptide entry
were compared with both the random- and the experi-
mental sets. Specifically, a confidential limit of number of
random peptide matches was calculated from the result of
100-fold random matching. If the number of matches
with the set of experimental product ions was greater than
the 95% upper confidence limit, the in silico peptide was
selected. Finally, the selected in silico peptides were
mapped back to the genome sequence according to their
position stored in the database.
Potential coding-sequence generation
A total of 153,202 possible ORFs (from start- to stop
codons including alternative ORFs) found in the E. coli
genome were generated in all 6 reading frames, irrespec-
tive of any previous annotation. Each putative ORF was
initially scored using the Z-transformed number of exper-
imental peptides that mapped to it. The putative ORFs
were further screened by comparing their estimated MW
with the known MW of sample proteins. The MWs (Da) of
the putative ORFs were estimated based on the linear cor-
relation with length (L, bp) using the equation MW =
181.4 + 36.9 L. This formula was derived from docu-
mented ORF-and protein-sequence information held in
the NCBI GenBank database. ORFs with a total calculated
MW that differed by more than 4,000 Da from that of the
experimental proteins were eliminated. The resulting
putative ORFs were assumed to encode the queried sam-
ple proteins. The search algorithm was implemented
using Perl version 5.8.
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